EyePoint Pharmaceuticals (NASDAQ: EYPT) today announced the appointment of John Landis, Ph.D., M.S., to the Company’s Board of Directors. Dr ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE